Loteprednol Etabonate Ophthalmic Gel 0.5% Following Cataract Surgery: Integrated Analysis of Two Clinical Studies.

CONCLUSION: LE gel 0.5% was efficacious and well tolerated in the treatment of postoperative pain and inflammation following ocular surgery, with minimal risk of IOP elevation. PMID: 24136301 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24136301?dopt=Abstract

Source: Advances in Therapy - October 18, 2013 Category: Drugs & Pharmacology Authors: Rajpal RK, Fong R, Comstock TL Tags: Adv Ther Source Type: research